Company / Capital Expenditures
Eledon Pharmaceuticals, Inc. Capital Expenditures History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$25.0K
FY2016
5-year range
$8.0K / $25.0K
FY2014-FY2016
Trend
+8.7%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $8,000 to $25,000 over the past 2 years.
Based on SEC 10-K filings.
$25,000 in FY2016.
Improved from $8,000 to $25,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, capital expenditures increased 8.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $25.0K | +8.7% |
| FY2015 | $23.0K | +187.5% |
| FY2014 | $8.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026